WO2010095912A3 - 난용성 약물 나노복합체의 제조방법 - Google Patents

난용성 약물 나노복합체의 제조방법 Download PDF

Info

Publication number
WO2010095912A3
WO2010095912A3 PCT/KR2010/001117 KR2010001117W WO2010095912A3 WO 2010095912 A3 WO2010095912 A3 WO 2010095912A3 KR 2010001117 W KR2010001117 W KR 2010001117W WO 2010095912 A3 WO2010095912 A3 WO 2010095912A3
Authority
WO
WIPO (PCT)
Prior art keywords
nanocomplex
soluble drug
manufacturing non
manufacturing
provides
Prior art date
Application number
PCT/KR2010/001117
Other languages
English (en)
French (fr)
Other versions
WO2010095912A2 (ko
Inventor
권대혁
신철수
신재윤
Original Assignee
성균관대학교 산학협력단
주식회사 에이피테크놀로지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성균관대학교 산학협력단, 주식회사 에이피테크놀로지 filed Critical 성균관대학교 산학협력단
Publication of WO2010095912A2 publication Critical patent/WO2010095912A2/ko
Publication of WO2010095912A3 publication Critical patent/WO2010095912A3/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1275Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)

Abstract

본 발명은 난용성 약물을 가용화할 수 있는 난용성 약물 나노복합체의 제조방법을 제공하는 것이며, 구체적으로 본 발명은 난용성 약물 및 아포리포단백질의 나노복합체를 높은 수율로 제조할 수 있는 제조방법을 제공한다.
PCT/KR2010/001117 2009-02-23 2010-02-23 난용성 약물 나노복합체의 제조방법 WO2010095912A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20090014908 2009-02-23
KR10-2009-0014908 2009-02-23

Publications (2)

Publication Number Publication Date
WO2010095912A2 WO2010095912A2 (ko) 2010-08-26
WO2010095912A3 true WO2010095912A3 (ko) 2010-12-09

Family

ID=42634360

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/001117 WO2010095912A2 (ko) 2009-02-23 2010-02-23 난용성 약물 나노복합체의 제조방법

Country Status (2)

Country Link
KR (1) KR101131202B1 (ko)
WO (1) WO2010095912A2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101455909B1 (ko) * 2012-01-20 2014-11-03 성균관대학교산학협력단 pH-반응 고밀도 리포단백질-유사 입자 결합체
KR101679118B1 (ko) 2014-06-23 2016-11-24 서울대학교산학협력단 폴리감마글루타민산 유도체 및 이를 함유한 제제

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005081743A2 (en) * 2004-01-13 2005-09-09 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287590B1 (en) * 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
KR100817024B1 (ko) 2006-11-09 2008-03-26 재단법인 목암생명공학연구소 핵산 또는 약물을 간에 특이적으로 전달하는 복합체 및이를 포함하는 약학적 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005081743A2 (en) * 2004-01-13 2005-09-09 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ABHINAV NATH ET AL.: "Applications of Phospholipid Bilayer Nanodiscs in the Study of Membranes and Membrane Proteins", BIOCHEMISTRY, vol. 46, no. 8, 2007, pages 2059 - 2069, XP055218872, DOI: doi:10.1021/bi602371n *
TANAKA M.: "Effects of Membrane Structure on Apolipoprotein A-1 Binding to Lipid", YAKUGAKU ZASSHI, vol. 127, no. 11, 2007, pages 1843 - 1849 *
TIMOTHY H. BAYBURT ET AL.: "Self-Assembly of Discoidal Phospholipid Bilayer Nanoparticles with Membrane Scaffold Proteins", NANO LETTERS, vol. 2, no. 8, 2002, pages 853 - 856, XP002304652, DOI: doi:10.1021/nl025623k *

Also Published As

Publication number Publication date
KR101131202B1 (ko) 2012-04-05
WO2010095912A2 (ko) 2010-08-26
KR20100096038A (ko) 2010-09-01

Similar Documents

Publication Publication Date Title
WO2011061032A3 (de) Zellen, nukleinsäuren, enzyme und deren verwendung sowie verfahren zur herstellung von sophorolipiden
WO2010122578A3 (en) Process for preparation of sitagliptin and its intermediates
WO2011060126A3 (en) Low-carbon fertilizers and processes for producing the same
WO2011057871A3 (de) Verwendung eines zu einem meab-protein homologen proteins zur erhöhung der enzymatischen aktivität einer 3-hydroxycarbonsäure-coa-mutase
EP2655795A4 (en) Multi-stage fracture injection process for enhanced resource production from shales
EP2170798A4 (en) HIGH SHEAR PROCESS FOR THE PRODUCTION OF ACETALDEHYDE
WO2011022548A3 (en) Ketoreductase polypeptides for the preparation of phenylephrine
PL2297079T3 (pl) Proces wytwarzania kwasu glikolowego
WO2011019465A3 (en) Integrated biodiesel production process
WO2012025944A3 (en) Sitagliptin, salts and polymorphs thereof
EP2431347A4 (en) Process for production of olefins
WO2010102778A3 (de) Substituierte 3-aminoisoxazolopyridine als kcnq2/3 modulatoren
ZA201103390B (en) Process for the manufacture of p4o6 with high yield
WO2012049307A3 (en) Novel n-terminally modified insulin derivatives
EP2669382A4 (en) Cellulosic biomass treatment method, method of producing sugar, alcohol or organic acid from cellulosic biomass
WO2012087670A3 (en) Genetically engineered microorganisms comprising 4-hydroxybenzoyl-coa thioesterases and methods of using the same
IT1397646B1 (it) Collagenasi ricombinanti di c. histolyticum e metodo per la loro produzione.
EP2515169A4 (en) FOTOMASKENROHLING AND METHOD FOR PRODUCING A PHOTOMASK
EP2137100A4 (en) HIGH SHEAR PROCESS OF CHLORAL PRODUCTION
EP2412696A4 (en) METHOD FOR PRODUCING 3-METHYL-CYCLOPENTADECENONE, PROCESS FOR PRODUCTION OF R / S-MUSCONE, AND PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE MUSCONE
WO2010015656A3 (en) Alkoxypyrazoles and the process for their preparation
WO2011067236A3 (de) Raltegravir-polymorphe
EP2589662A4 (en) Process for production of useful substance
WO2011023954A3 (en) Polymorphic forms of manidipine
PL2513291T3 (pl) Nowe szczepy drożdży do wytwarzania alkoholu

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10743987

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10743987

Country of ref document: EP

Kind code of ref document: A2